Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells.

JSON

Van der Meer JMR, Maas RJA, Guldevall K, Klarenaar K, De Jonge PKJD, Hoogstad-van Evert JS, van der Waart AB, Cany J, Safrit JT, Lee JH, Wagena E, Friedl P, Önfelt B, Massuger LF, Schaap NPM, Jansen JH, Hobo W, Dolstra H

Cancer Immunol. Immunother. 70 (11) 3367 [2021-11-00; online 2021-09-16]

PubMed 34524494

DOI 10.1007/s00262-021-03049-5

Crossref 10.1007/s00262-021-03049-5

pmc: PMC8505330
pii: 10.1007/s00262-021-03049-5